Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem
- 31 July 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hospital Infection
- Vol. 60 (3), 226-230
- https://doi.org/10.1016/j.jhin.2005.04.001
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Controlling methicillin resistant Staphylococcus aureusBMJ, 2003
- Evolution of Sporadic Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA) in Hospitals and Their Similarities to Isolates of Community-Acquired MRSAJournal of Clinical Microbiology, 2003
- Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burnsBurns, 2003
- Absence of risk factors for community MRSAClinical Microbiology & Infection, 2003
- A comparison of the antimicrobial effects of four silver-containing dressings on three organismsJournal of Wound Care, 2003
- Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificatesBMJ, 2002
- Temporal Changes in Prevalence of Antimicrobial Resistance in 23 U.S. HospitalsEmerging Infectious Diseases, 2002
- Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healingWound Repair and Regeneration, 2002
- Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysisThe Medical Journal of Australia, 2001
- The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian HospitalsInfection Control & Hospital Epidemiology, 2001